We are lowering our target price of Bristol Myers despite a profit rate
Bristol Myers Squibb and Rosy Outlook's profits on Thursday did not solve persistent problems for actions. But it was enough,…
amgen inc
Trump says that pharmaceutical rates are arriving, the actions fall
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters The actions of drug…
Trump tariffs will challenge the big pharmaceuticals. Here are well positioned actions
Long Data Commercial Agreements have greatly protected the pharmaceutical industry of tariffs, but the objective of President Donald Trump to…
Amgen's weight loss drug maritid begins two phase three tests
The Amgen logo is shown outside Amgen's headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty…
Eli Lilly Dan Skovronsky discusses weight loss drugs
Dan Skovronsky knows what a good drug of obesity does. As head of scientific officer in Eli LillyHe has already…
Eli Lilly and Amazon announce agreements at JPMorgan conference
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Eli Lilly's lead in the obesity race has increased. Its recent stock performance says otherwise.
Eli Lilly investors have received some very good news in recent months, with one notable exception regarding the stock's performance.…
FDA approvals fall in 2024, Transcarent acquires Accolade
Signs are seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, on August 29, 2020. Andrew…
Wall Street mulls data on weight-loss drug Amgen
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Amgen says anti-obesity drug MariTide caused up to 20% weight loss after one year
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…